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A study in Nature by Fischer et al. shows that environmental enrichment or increasing histone acety-
lation rescue the ability to form new memories and re-establish access to remote memories even in the
presence of brain degeneration. Chromatin remodeling may be the final gate environmental enrich-
ment opens to enhance plasticity and represents a promising target for therapeutical intervention in
neurodegenerative diseases.Exposure to enriched environment
(EE) potently modulates synaptic
plasticity and learning and memory
processes. Effects of EE have been
observed in developing, adult, and
aging animals (Cancedda, et al., 2004;
Nithianantharajah and Hannan, 2006).
In laboratories, exposure to EE is
achieved by housing animals (rodents)
in large cages where exploratory activ-
ity is promoted by the presence of a
variety of toys, tunnels, and climbing
devices. A recent study in Nature by
Fischer et al. suggests that these
enrichment effects might be mediated,
at least in part, by chromatin remodel-
ing (Fischer et al., 2007).
Fischer et al. examined the benefi-
cial effects of EE in a mouse model,
the p25 transgenic mouse, which al-
lows temporally and spatially re-
stricted induction of neuronal loss.
The p25 protein has been implicated
in various neurodegenerative dis-
eases, including Alzheimer’s disease
(Cruz and Tsai, 2004). The authors
had previously demonstrated that,
upon induction of the p25 transgene
in adult mice, neurodegeneration is
triggered, and animals also display
both learning and memory impair-
ments (Fischer et al., 2005). Six weeks
after switching the transgene on, mice
are not only unable to form new
memories but they are also unable to
retrieve memories acquired before
the transgene was switched on. Now,
Fischer et al. have used this model
system to assess whether EE has ben-
eficial effects in this transgenic animal
model (Fischer et al., 2007). Six weeks
after induction of p25, when anatomi-
cal and functional deficits are well es-508 Neuron 54, May 24, 2007 ª2007 Elsetablished, the authors transferred the
animals into an EE for 4 weeks. Sur-
prisingly, the authors found that this
rescued the mice’s ability to form
new memories (i.e., the mice learned
a new fear conditioning and a new
spatial task) and also allowed the
mice to re-establish access to remote
memories learned prior to brain de-
generation, all of this despite the fact
that the neuronal loss did not recover
(Figure 1). It is important to note that
the new memories formed by the
mice required the hippocampus, while
remembering the remote memories
likely involved accessing neocortical
networks, as these remote memories
would have been progressively trans-
ferred from the hippocampus to the
neocortex over time. Indeed, while
recall of recent memories activates
the hippocampus and hippocampal
lesions impair this recall, remote mem-
ory retrieval is impaired by cortical
lesions, and their recall activates corti-
cal areas (Frankland and Bontempi,
2005). The fact that EE restores both
new learning and access to remote
memories suggests that the effects of
EE are probably widespread within
hippocampal and cortical areas.
What caused the effects reported by
Fischer et al.? The authors demon-
strated that synaptic-related proteins
were increased in EE mice, indicating
the presence of new dendritic branch-
ing and activation of synaptogenesis.
This increase was seen in both the hip-
pocampus and the cortex, strengthen-
ing the idea that the behavioral effects
they reported might be related to these
anatomical changes. Prior studies had
also shown an effect of EE on neuralvier Inc.connectivity, and these results had
been taken as an indication that syn-
aptic plasticity was induced. But the
authors also went a step further. They
first demonstrated that EE increased
histone acetylation in the hippo-
campus and, to a lesser extent, in the
cortex of wild-type mice. Histone post-
translational modifications regulate
chromatin susceptibility to transcrip-
tion: high levels of histone acetylation
on a specific DNA segment is generally
correlated with increased transcription
rates. The effects of EE on wild-type
mice suggested that the effects of EE
in the p25 transgenic mice might be
mediated, at least in part, by histone
acetylation. Indeed, the authors also
found that promoting histone acetyla-
tion by means of administration of his-
tone deacetylation inhibitors to these
mice also promoted synaptogenesis
and recovery from learning and mem-
ory deficits, similar to that seen with
exposure to EE. Beneficial effects of
histone acetylation in memory-related
plasticity had previously been descri-
bed both in WT animals and in animal
models of human mental retardation
(Alarcon et al., 2004; Korzus et al.,
2004; Levenson and Sweatt, 2005).
The importance of the Fischer et al. re-
sults is that they show, for the first
time, that promoting histone acetyla-
tion restores learning and the access
to long-term memories in a degener-
ated brain, after synaptic and neuronal
loss had already occurred and in the
absence of neuronal regeneration.
Similar beneficial relationships be-
tween histone acetylation states and
EE effects have also recently been
shown to exist in the visual system.
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lated by visual experience, and this
affects subsequent experience-
dependent plasticity in the visual
cortex (Putignano et al., 2007). Vi-
sual experience activates histone
acetylation during the critical period
for ocular dominance plasticity, but
its action becomes downregulated
in adult animals, in correlation with
the lower levels of adult cortical
plasticity: this suggests that, as it
does with plasticity of visual cortical
connections, visual experience pro-
gressively reduces its own effec-
tiveness in regulating gene tran-
scription and/or modifies the
ensemble of regulated genes (Maj-
dan and Shatz, 2006). Trichostatin
treatment, which promotes histone
acetylation in the visual cortex,
also enhances adult visual cortical
plasticity (Putignano et al., 2007).
Similarly, EE in adult rats promotes
recovery from a pathological reduc-
tion in visual acuity arising from a de-
fective visual experience during de-
velopment (amblyopia) (Sale et al.,
2007). Monocular deprivation dur-
ing the critical period causes strong
modifications in visual cortical cir-
cuits and leads to loss of vision in
the deprived eye. While visual acuity
recovers if normal vision is restored
to the deprived eye during the criti-
cal period, very little recovery is ob-
served in adult animals. Sale et al.
showed that when they reopened
the deprived eye in adult rats and
exposed these amblyopic animals
to EE, these rats recovered normal
visual acuity in the formerly de-
prived eye. The effects of enrich-
ment seemed to be mediated by
a reduction in the intracortical inhib-
itory tone in the visual cortex: EE an-
imals showed a reduction in GABA
release, while enhancing GABA ac-
tion by diazepam infusion into the vi-
sual cortex prevented EE-induced re-
covery of visual acuity. This recovery
was also associated with modulation
of other factors known to be involved
in visual cortical plasticity (e.g., BDNF
and extracellular matrix components,
chondroitin sulfate proteoglycans
[CSPGs]; Pizzorusso et al., 2002). In
particular, BDNF was shown to be
upregulated in the visual cortex of
enriched animals, and the assembly
of CSPGs in perineuronal nets (PNNs)
was reduced (Sale et al., 2007).
The studies on the effects of EE on
memory (Fischer et al., 2007) and adult
visual cortical plasticity (Sale et al.,
2007) nicely complement each other.
It is possible that the cellular and mo-
lecular mechanisms proposed to
mediate the effects of EE on adult vi-
sual cortical plasticity could be
upstream of the histone acetylation
effects reported by Fischer et al.,
thus filling the gap between EE and
control of chromatin remodeling.
Taken together, the results of these
twopapers allow one todrawa tenta-
tive scenario linking EE with the acti-
vation of gene transcription pro-
grams leading to plastic changes
that subserve functional recovery
(Figure 2). This interpretation is
strengthened by the fact that the
two very different models of plastic-
ity used in Sale et al. and Fischer
et al. share two common features,
sensitivity to EE and to histone acet-
ylation. Indeed, promoting histone
acetylation enhances plasticity both
in the visual cortex (Putignano et al.,
2007) and in different learning and
memory systems (Fischer et al.,
2007; Alarcon et al., 2004; Korzus
et al., 2004), as is the case for EE,
which promotes recovery both in
amblyopic rats and in p25 mice.
This strongly suggests that epige-
netic control of gene transcription
through histone acetylation could
be the final gate opened by EE to
promote plasticity.
EE has been demonstrated to
be beneficial in reducing cognitive
deficits and the progression of the
disease in several models of neuro-
degenerative pathologies related to
human diseases, such as Hunting-
ton’s and Alzheimer’s, and in pre-
venting neurodegeneration caused
by different types of insults (ische-
mic, traumatic) (Nithianantharajah
and Hannan, 2006; Berardi et al.,
2007; Lazarov et al., 2005). In these
models, many of the factors regu-
lated by EE are neuroprotective,
promote plasticity, and ameliorate
behavioral and morphofunctional defi-
cits. Could this be true also for histone
acetylation? Fischer et al. provide
some support for this idea by showing
that histone deacetylation inhibitors al-
low cognitive recovery after behavioral
and anatomical pathology are already
established. It is hoped that studies
such as these will eventually allow
Figure 1. Induction of p25 for 6 Weeks
(Starting at 11 Months of Age) Induces Brain
Atrophy, Neurodegeneration, and Learning
and Memory Impairments
(A) Exposure to EE for 4 weeks reinstates normal
learning and memory despite the persisting brain
atrophy. EE in WT mice increased histone acetyla-
tion (see text). Daily injections of histone deacety-
lase inhibitor sodium butyrate (SB) for 4 weeks de-
termine effects similar to EE in non-EE p25 mice.
(B) Mice were trained in two learning tasks and then
returned to their home cages. After 4 weeks, in
some of the mice p25 was induced for 6 weeks,
causing neurodegeneration. Mice were either put
in an EE or kept in their home cages for 4 weeks.
Non-EE p25 mice showed loss of memory of
what they had learned 14 weeks before; EE p25
mice showed a marked recovery of long-term
memory. Also in this case, brain atrophy was not
affected by EE. The same effect was obtained in
p25 mice treated with SB for 4 weeks.Neuron 54, May 24, 2007 ª2007 Elsevier Inc. 509
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cess such that this mechanism might
be exploited to its full potential as
a ‘‘behavioral therapy’’ in humans. In
addition, EE animals can be viewed
as potential models to fish out mole-
Figure 2. Diagram Showing the Possible
Mechanisms of Action of EE on
Functional and Structural Plasticity510 Neuron 54, May 24, 2007 ª2007 Elsecules that mediate the beneficial ef-
fects of EE and that might someday
be used to develop possible therapeu-
tic agents for humans. It should be
stressed that the Fischer et al. (2007)
study does not directly address
whether promoting histone acetylation
might be beneficial in human neurode-
generative pathologies, given that it re-
mains unknown whether the elegant
mouse model used in their studies truly
recapitulates all the features found in
patients affected by neurodegenera-
tive diseases such as Alzheimer’s
disease. However, by increasing our
knowledge on the cellular and molecu-
lar mechanisms underlying EE’s bene-
ficial effects, papers like those dis-
cussed here pave the way for the
possibility that therapeutic applica-
tions for humans may well be devel-
oped in the future.
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